Variables | Overall survival | |||||
---|---|---|---|---|---|---|
 | Univariate analysis | Multivariate analysis | ||||
 | HR | 95%CI | p | HR | 95%CI | p |
Age (years), </≥60 | 1.185 | 1.305–2.129 | 0.747 |  |  |  |
Sex, (male/female) | 0.583 | 0.392–2.470 | 0.274 |  |  |  |
BMI, (kg/m2), </≥25 | 1.191 | 0.726–1.103 | 0.125 |  |  |  |
ECOG (0/1) | 1.182 | 0.943–2.734 | 0.282 |  |  |  |
Hepatitis B, (yes/no) | 1.688 | 0.769–2.650 | 0.511 |  |  |  |
Hepatitis C, (yes/no) | 1.352 | 0.144–2.013 | 0.206 |  |  |  |
AFP (ng/ml), </≥400 | 1.566 | 0.072–2.317 | 0.114 |  |  |  |
Child-Pugh (A/B) | 2.403 | 2.500–8.434 | 0.005 | 2.633 | 1.391–9.648 | 0.001 |
BCLC (B/C) | 1.390 | 0.651–2.591 | 0.171 |  |  |  |
Liver cirrhosis (yes/no) | 1.772 | 0.785–3.647 | 0.663 |  |  |  |
PD-L1 expression | 1.473 | 0.860–3.429 | 0.052 |  |  |  |
Tumor thrombus | Â | Â | Â | Â | Â | Â |
Absent | Â | Â | Â | Â | Â | Â |
Branch of portal vein | 1.583 | 0.303–4.752 | 0.545 |  |  |  |
Main portal vein | 1.276 | 0.295–6.298 | 0.901 |  |  |  |
Extrahepatic metastasis (yes/no) | 1.292 | 0.747–3.842 | 0.118 |  |  |  |
Number of metastatic sites (< 3/≥3) | 2.104 | 1.360–4.476 | 0.007 | 2.193 | 1.187–4.366 | 0.002 |
Treatment (PLH/PL) | 2.499 | 1.726–4.902 | 0.005 | 3.649 | 1.592–6.074 | 0.001 |